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Available online 11 December 2014AbstractBackground: Adenomatoid odontogenic tumor (AOT) is an uncommon benign epithelial odontogenic tumor. Expert morpho-
logical diagnosis is required to establish differential diagnosis, in particular from ameloblastoma, thus preventing extensive surgery.
Objective: To clarify the histopathological features of AOT, as well as to assess the immunohistochemical expression of survivin in
AOT.
Material and methods: Ten specimens of AOT, and one specimen of tooth germ as a control were collected from the archival files
of Oral Pathology Department, Faculty of Dentistry, Alexandria University, Egypt. The expression of survivin was assessed by
immunohistochemical methods.
Results: Our results revealed that all the cases of AOT, as well as the tooth germ were immunoreactive to survivin.
Conclusion: The expression of survivin in AOT, suggested that the family protein survivin contributes to the biological properties
of AOT, such as cell survival, proliferation, differentiation and tissue structuring, as well as cellular regulation during tooth
development.
© 2014, Hosting by Elsevier B.V. on behalf of the Faculty of Dentistry, Tanta University.
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Adenomatoid odontogenic tumor (AOT) is an un-
common benign epithelial odontogenic tumor, repre-
senting almost 3% of all odontogenic tumors [1].
The origin of AOT remains uncertain. This has
posed problems in its classification. AOT was included* Corresponding author.
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Open access under CC BY-NC-ND license.in the spectrum of mixed odontogenic tumors in 1992
WHO classification [2]. Lately, it was considered as an
epithelial odontogenic tumor in 2005 WHO classifi-
cation. Philipsen et al. [3], had strongly reported that
AOT was derived from dental lamina or its remnants,
although there is evidence that the tumor cells are
derived from enamel organ epithelium. Most reports
[4,5] have shown that AOT commonly presents as a
slowly growing, painless mass often involving the
anterior maxilla, and with 3 clinical subtypes, all with
identical histology: follicular type (73%), the extra-
follicular variant (24%), and finally the peripheral formentistry, Tanta University.
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benign neoplasm by most authors, although some have
classified them as hamartomas [6,7].
In spite of previous confusing denominations, such
as adeno-ameloblastoma, or Adenomatoid amelo-
blastic tumors [8], AOT is a benign tumor with a very
low rate of recurrence, and appears most often in the
second decade of life [1].
Survivin belongs to apoptosis inhibitor gene family,
in which the proteins characterized by a domain of
about 70 amino acids, termed baculovirus inhibitor of
apoptosis proteins (IAPs). Survivin is a multifunctional
protein that suppresses apoptosis by inhibiting one or
more caspases and regulates mitosis by interacting
with other chromosomal passenger protein [9e11].
Some studies have shown that some oncogenic
mutations can disrupt apoptosis, leading to tumor
initiation, progression or metastasis [12,13]. In
mammalian cells, apoptosis is mainly modulated by
two protein families, the bcl-2 and (IAPs) to which
survivin belongs [14].
Survivin protein is expressed highly in most
human tumors and fetal tissues [15], but is completely
absent in differentiated cells [16]. This fact therefore
makes survivin an ideal target for cancer therapy as
cancer cells are targeted while normal cells are left
alone [17]. Furthermore, survivin is likely to be
involved in tumor cells resistance to radiation and
chemotherapeutic drugs, and high expression levels
of survivin also correlates with increased rate of
tumor recurrence [14,18]. In this study, the reason for
choosing survivin marker was its previously docu-
mented potential therapeutic target for epithelial
odontogenic tumor.
This work aimed to clarify the histopathological
features of AOT as well as to assess the immunohis-
tochemical expression of survivin in AOT.
2. Material and methods
Ten surgical specimens of AOT were selected from
the files of Oral Pathology Department, Faculty of
Dentistry, Alexandria University, through the period
from 2005 to 2013. The studied cases include nine
follicular AOT and one extrafollicular AOT. One biopsy
specimen of normal tooth germ was taken as control.
2.1. Immunohistochemistry
All samples were fixed in buffered formalin and
embedded in paraffin, four-micrometer sections were
obtained from each tumor and dispensed on coatedslides. Sections were deparaffinized and immersed in
methanol with 3% hydrogen peroxide. They were
submitted to antigen retrieval solution before
applying the anti-survivin (dilution 1:1000 poly-
clonal, Dako Corp, Carpentaria, CA, USA) antibody
and incubated for 30 min at room temperature. The
reaction was amplified using a streptavidin-biotin
peroxidase immunostaining method. Dia-
minobenzidine was used as chromagen: followed by
counter-staining with Mayer's hematoxylin, and
finally cover slipped.
2.2. Immunohistochemical assessment
The immunostaining reaction of survivin was eval-
uated according to the intensity and pattern of distri-
bution. The positive immunohistochemical staining for
survivin appeared as nuclear brownish reaction and
sometimes cytoplasmic reaction was noted.
Nuclear or cytoplasmic staining for survivin were
scored as positive when staining reaction was noted in
more than 10% of the tumor cells, and negative when
staining reaction was noted in less than 10% of the
tumor cells [19].3. Results
Ten cases of adenomatoid odontogenic tumor
(AOT) and one tooth germ were analyzed for the
expression of antiapoptotic protein survivin. The tooth
germ was considered as control. A written informed
consent was taken from all the patients. This was
approved by the research ethics committee.
3.1. Clinical findings
The median age of the patients was 14 years,
ranging from 4 to 25 years. All the studied cases were
females. The most common site of occurrence was
the anterior portion of maxilla in the canine area
(Fig. 1).
3.2. Histopathological results
The Adenomatoid odontogenic tumor cases
exhibited spindle shaped epithelial cells that form
whorled masses in scant fibrous stroma (Fig. 2a), as
well as characteristic preameloblast like cells forming
duct like structure (Fig. 2b, c). Some foci of basophilic
cementum-like structures were noted scattered
throughout the stroma (Fig. 2d).
Fig. 1. Common site of occurrence the anterior portion of maxilla in
the canine area.
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Immunohistochemical reactivity for survivin was
detected as a brownish reaction observed in cytoplasm
as well as in the nucleus. The examined tooth germ
specimen was positive to survivin. Immunosignals
were more evident in the inner enamel epithelium thanFig. 2. Histopathological Staining of Adenomatoid Odontogenic Tumor (A
whorled masses in fibrous stroma. b. Characteristic preameloblast like cells
photo micrograph exhibited duct like structure. d. Foci of basophilic cemein outer enamel epithelium and dental lamina (Fig. 3a).
Expression of antiapoptotic protein survivin was
detected in 100% of the studied cases of AOT.
Intense survivin immunoexpression was detected in
the odontogenic spindle epithelial cells projecting from
the cyst lining (Fig. 3b, c, d, e), as well as in the pre-
ameloblast like cells forming the duct like structures
(Fig. 3f).
4. Discussion
The development of a tumor, whether benign or
malignant involves a series of genetic events with
abnormal activation of cellular oncogenes or inactiva-
tion of tumor suppressor genes [20,21]. Some of these
events aim to stimulate the release of certain sub-
stances inside the tumor cells which maintain their
viability and enhance their survival.
Survivin, a member of IAP-family, is essential for
cell division, as well as inhibitor of apoptosis with dual
roles in promoting cell proliferation, and preventing
apoptosis [22,23], it is considered as protein that in-
terfaces life and death. Unlike bcl-2 family members
that induce their antiapoptotic effects through regu-
lating the intrinsic pathway, IAPs act predominantly by
directly binding and inhibiting initiators as well as
caspases, thus providing a separate and non-redundant
pathway of cell viability in cancer [24].OT) showing: a. Spindle shaped odontogenic epithelial cells forming
forming duct like structure. c. Higher magnification of the previous
ntum-like structures scattered throughout the stroma (H&E 200).
Fig. 3. Immunohistochemical staining of Adenomatoid Odontogenic Tumor (AOT) showing: a. Immunosignals are more evident in inner enamel
epithelium than outer enamel epithelium and dental lamina. b. Intense survivin reaction in odontogenic spindle epithelial cells projecting from the
cyst lining. c. Intense survivin reaction in the whorled pattern appearance of AOT. d. Intense survivin immunosignals are also noted. e. Survivin
immunopositivity in the pre-ameloblast like cells. f. Intense diffuse surviving reaction in the pre-ameloblast like cells forming the duct like
structure.
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tigating its presence in different kinds of neoplastic and
preneoplastic lesions all over the body. Among the
researched tumors are malignancies of lung, prostate,
breast carcinomas, malignant lymphoma, neuroblas-
toma [25e27], as well as preneoplastic lesions as
polyps of colon [28] and breast adenomas [26]. How-
ever, very few works have been done on survivin in
association with odontogenic tumors. Moreover, there
are no reported data concerning its expression in AOT.
Apoptosis, also known as programmed or physio-
logical cell death, plays diverse roles in embryogenesis
and normal homeostasis, as well as in oncogenesis
[29,30]. Apoptotic processes are modulated by various
factors, which have inhibitory or stimulatory effects.
Survivin, is a unique bifunctional protein which sup-
presses apoptosis by inhibiting caspase 3 and 7 as wellas regulate the G2/M phase of the cell cycle by asso-
ciating with mitotic spindle microtubules [14].
In the present research, the specimen of tooth germ
examined for the presence of survivin, showed positive
immunoreactions to antiapoptotic survivin in the inner
and outer enamel epithelium. This is in accordance
with Kumanoto et al. [31]. They attributed that survivin
plays a role in cell survival and differentiation
throughout the different phases of tooth development.
Moreover, Voahtokari et al. [32], reported that,
expression of survivin during embryonic and fetal
development may contribute to tissue homeostasis and
differentiation. Furthermore, they stated that apoptotic
cell death has a significant role in tooth development.
AOT is an uncommon benign and usually cystic
tumor of odontogenic epithelial origin with duct-like
structures, and exerts various degrees of inductive
178 S.M. ElSheikh et al. / Tanta Dental Journal 11 (2014) 174e179effects on adjacent mesnechyma [7]. The increasing
number of reports on AOT points to the fact that the
tumor develops more frequently than formerly ex-
pected [33].
In the present work, the 10 examined cases of AOT,
showed positive immunoreactions to survivin. The re-
action was detected mainly in the duct like structure as
well as the spindle cells forming the whorled pattern.
This is in agreement with Kumanoto et al. [31], in their
work on ameloblastoma. They interestingly stated that
all the peripheral layers of ameloblastomatous follicles
were stained intensely by survivin. Moreover, some
investigators [34] detected two pattern for amelo-
blastoma: an antiapoptotic proliferating area in the
outer layer (periphery), that morphologically resemble
the preameloblasts or ameloblast like-cell, and a pro-
apoptotic differentiating region in the inner layer
(center). This explains the positive reaction to survivin
in the examined cases of AOT. These findings suggest
that survivin expression is associated with cell prolif-
eration and differentiation of AOT cell.
It should be noted that the dynamics of molecules
and genetic interplay cannot be reflected in their entirely
by immunohistochemistry at any particular point in time
[35,36]. Therefore, ultrastrctural studies or more so-
phisticated methods, such as cytogentics and molecular
analysis may be needed to clarify the histogenesis and
behavior of AOT. In conclusion, the expression of sur-
vivin in AOT, suggests that it contributes to the bio-
logical properties of AOT, such as cell survival,
proliferation, differentiation and tissue structuring, as
well as to cellular regulation during tooth development.
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